ASX - Delayed Quote • AUD ImpediMed Limited (IPD.AX) Follow Compare 0.0530 0.0000 (0.00%) At close: 4:10:36 PM GMT+11 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations ImpediMed Leads Our Trio Of ASX Penny Stock Highlights The Australian market has recently experienced a downturn, with the ASX200 breaking its five-day rally and sectors across the board showing declines. Despite this, opportunities still exist for investors willing to explore lesser-known areas of the market. Penny stocks, though an older term, continue to represent potential growth avenues by focusing on smaller or newer companies that combine affordability with promising fundamentals. 3 ASX Penny Stocks With Market Caps Larger Than A$30M The Australian market has recently faced challenges, with the ASX200 dipping slightly and sectors like energy and financials underperforming due to falling commodity prices and economic concerns. In such a climate, investors often seek opportunities that balance potential growth with manageable risk, making penny stocks an intriguing option. Although considered a somewhat outdated term, penny stocks still represent affordable entry points into smaller or newer companies that may offer growth... We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... Brookside Energy And 2 Other ASX Penny Stocks To Watch The Australian market remains buoyant, with the ASX200 closing up 0.84% at 8,295 points amid positive expectations for global economic developments. In such a vibrant market landscape, identifying stocks with solid fundamentals becomes crucial for investors seeking to capitalize on growth opportunities. Penny stocks, while often seen as relics of past trading days, still hold potential when backed by strong financials and can offer a unique mix of affordability and growth prospects. ImpediMed Limited (ASX:IPD): Are Analysts Optimistic? ImpediMed Limited ( ASX:IPD ) is possibly approaching a major achievement in its business, so we would like to shine... Investors in ImpediMed (ASX:IPD) have unfortunately lost 74% over the last year As every investor would know, you don't hit a homerun every time you swing. But it's not unreasonable to try to avoid... Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... ImpediMed's (ASX:IPD) investors will be pleased with their notable 72% return over the last year While ImpediMed Limited ( ASX:IPD ) shareholders are probably generally happy, the stock hasn't had particularly good... Performance Overview Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return IPD.AX S&P/ASX 200 [XJO] YTD +1.92% +0.66% 1-Year -63.45% +9.56% 3-Year -69.71% +11.08%